28 January 2003
Experimental studies of serum cytokine concentration following pancreatic electrolytic ablation.
Charles P. Morrison, Benjamin D. Teague, Fiona G. Court, Simon A. Wemyss-Holden, Mathew S. Metcalfe, Ashley R. Dennison, Guy J. MaddernMed Sci Monit 2003; 9(1): BR43-46 :: ID: 4785
Abstract
BACKGROUND: Pancreatic cancer has a poor prognosis, with symptomatic palliation being the priority in the majority of cases. Alternative palliative techniques, such as local ablation, are under investigation. Palliative per-ductal electrolytic ablation of the pancreas has been reported, in an experimental series. It is important to establish that this technique is associated with low morbidity and mortality if it is to be acceptable. The 'systemic inflammatory response syndrome' (SIRS) is a recognised and serious complication of both acute pancreatitis, and certain locally ablative techniques. This study aimed to determine whether pancreatic electrolytic ablation is associated with an increase in serum IL-1ß and TNF-α concentrations, these cytokines playing integral roles in the inflammatory pathway of SIRS. MATERIAL/METHODS: Eight pigs underwent per-ductal electrolytic ablation of the pancreas. Serum samples, taken pre-operatively and post-operatively for two weeks, were analysed for IL-1ß and TNF-α concentrations. Variations in cytokine levels were statistically analysed. RESULTS: Post-operative serum IL-1ß and TNF-α concentrations did not significantly increase on pre-operative figures. There were no other clinical, biochemical or histological indicators of a SIRS-like phenomenon. CONCLUSIONS: The results from this study suggest that electrolytic ablation of normal pancreas is not associated with either an increase in serum concentrations of IL-1ß and TNF-α or a SIRS phenomenon. Although this study has only investigated the serum levels of two cytokines, IL-1ß and TNF-α have both been shown to have a central role in the inflammatory cascade that leads to SIRS.
Keywords: Catheter Ablation - methods, Cytokines - blood, Interleukin-1 - blood, Pancreas - pathology, Prognosis, Swine, Time Factors, Tumor Necrosis Factor-alpha - biosynthesis
519 2
Editorial
01 June 2023 : Editorial
Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic PreparednessDOI: 10.12659/MSM.941209
Med Sci Monit 2023; 29:e941209
In Press
08 Jun 2023 : Clinical Research
Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical Research
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical Research
Burden of COVID-19 on Mental Health of Resident Doctors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical Research
Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952